3M Health Care

V.A.C. Therapy. [Image from 3M]3M (NYSE:MMM) Healthcare’s Medical Solutions Division announced the surpassing of 2,000 published studies for its V.A.C. Therapy.

Maplewood, Minnesota-based 3M’s V.A.C. delivers negative pressure wound therapy (NPWT). The company said it’s the only NPWT tech to hit the milestone of 2,000 published, peer-reviewed medical journal studies.

According to a news release, V.A.C. therapy accounts for more than 75% of published NPWT clinical evidence.

“Clinical evidence has always been a foundational element to establishing credibility for V.A.C. Therapy and our NPWT products in the wound care community,” said Dr. Ronald Silverman, M.D., 3M Health Care SVP of clinical affairs and CMO. “Published studies have also helped to promote adoption of NPWT and spur therapy innovations, including 3M Prevena therapy for incision management, 3M Veraflo therapy for instillation therapy for open wounds, 3M AbThera…

A VAC Ulta therapy unit [Image from 3M]The 3M (NYSE:MMM) Health Care’s medical solutions business announced upgrades to advance the delivery of certain wound care technologies.

A new 3M Veraflo Cleans Choice Complete dressing kit and a software upgrade for the 3M VAC Ulta therapy unit were introduced at no increased cost to the customer.

3M said in a news release that the new offerings help to simplify the care delivery processes for clinicians using Veraflo negative pressure wound therapy with installation and help to make dressing changes easier, faster and less painful for patients when compared to previous Veraflo therapy dressings.

Veraflo therapy is used for patients with open soft issue wounds to help cleanse and stimulate the formation of granulation tissue. The company pointed to a recent publication — titled Effects of Negative-Pressure Wound Therapy with Instillation versus Standard of Care in Multiple Wound Types: Systematic Literature Rev…

3M (NYSE: MMM) announced today that it plans to spin off its Health Care business by the end of 2023.

The new Health Care business will be a roughly $9-billion-a-year company with a focus on wound care, oral care, healthcare IT and biopharma filtration. 3M officials argue that the transaction will better position Health Care to innovate. 3M will retain a 19.9% stake in Health Care that it will monetizedover time.

“Today’s actions advance our ability to create value for customers and shareholders,” 3M CEO Mike Roman said ina. news release. “Disciplined portfolio management is a hallmark of our growth strategy. Our management team and board continually evaluate the strategic options that will best drive long-term sustainable growth and value. The decision to spin off our Health Care business will result in two well-capitalized, world-class companies, well positioned to pursue their respective priorities.”